Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.

Sze, G

Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial. [electronic resource] - Investigative radiology Mar 1993 - S49-55 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study

0020-9996

10.1097/00004424-199303001-00006 doi


Central Nervous System Diseases--diagnosis
Contrast Media--toxicity
Female
Gadolinium--toxicity
Gadolinium DTPA
Humans
Injections, Intravenous
Magnetic Resonance Imaging
Male
Middle Aged
Organometallic Compounds--toxicity
Pentetic Acid--toxicity